Metabolomics: A tool for anticancer lead-finding from natural products

Planta Medica

Volumn 76, Issue 11, 2010, Pages 1094-1102

  Kim, Hye Kyong ^a   Wilson, Erica G ^a   Choi, Young Hae ^a   Verpoorte, Robert ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

anticancer; in silico; in situ; metabolomics; natural product; new approach

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CYTOTOXIC AGENT; NATURAL PRODUCT;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER THERAPY; CYTOTOXICITY; DNA FINGERPRINTING; DNA FOOTPRINTING; HUMAN; METABOLOMICS; NEUROBLASTOMA; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TOXICOLOGY; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AGENTS; BIOLOGICAL MARKERS; HUMANS; METABOLOMICS; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RATS;

EID: 77955080186     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1249898     Document Type: Review

References (66)

1. Newman D J., Cragg G M. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007 70 461-477
2. Verpoorte R, Choi Y H., Kim H K. Ethnopharmacology and systems biology: a perfect holistic match. J Ethnopharmacol 2005 100 53-56
3. Ulrich-Merzenich G, Zeitler H, Jobst D, Panek D, Vetter H, Wagner H. Application of the -omic- technologies in phytomedicine. Phytomedicine 2007 14 70-82
4. Rochfort S. Metabolomics reviewed: a new omic platform technology for systems biology and implications for natural products research. J Nat Prod 2005 68 1813-1820
5. Craige Trenerry V, Rochfort S J. Natural products research and metabolomics. Mander L, Liu H W Comprehensive natural products II: chemistry and biology. Amsterdam Elsevier 2010 595-628
6. Roos G, Rseler C, Berger-Bter K, Simmen U. Classification and correction of St. John's wort extracts by nuclear magnetic resonance spectroscopy, multivariate data analysis and pharmacological activity. Planta Med 2004 70 771-777
7. 1H-NMR spectroscopy and principal component analysis. Chem Pharm Bull 2005 53 105-109
8. Yang S Y., Kim H K., Lefeber A W. M., Erkelens C, Angelova N, Choi Y H., Verpoorte R. Application of two-dimensional nuclear magnetic resonance spectroscopy to quality control of ginseng commercial products. Planta Med 2006 72 364-369
9. 1H-NMR spectroscopy and multivariate data analysis. Plant Physiol 2004 135 2398-2410
10. Liang Y-S, Choi Y H., Kim H K., Linthorst H J. M., Verpoorte R. Metabolomic analysis of methyl jasmonate treated Brassica rapa leaves by two dimensional NMR spectroscopy and multivariate analysis. Phytochemistry 2006 67 2503-2511
11. Leiss K A., Choi Y H., Abdel-Farid I B., Verpoorte R, Klinkhamer P G. L. NMR metabolomics of thrips (Frankliniella occidentalis) resistance in Senecio hybrids. J Chem Ecol 2009 35 219-229
12. 1H NMR and multivariate analysis technique. Phytochemistry 2004 65 857-864
13. Le Gall G, Metzdorff S B., Pedersen J, Bennett R N., Colquhoun I J. Metabolite profiling of Arabidopsis thaliana (L.) plants transformed with an antisense chalcone synthase gene. Metabolomics 2005 1 181-198
14. Sumner L W., Mendes P, Dixon R A. Plant metabolomics: large-scale phytochemistry in the functional genomics era. Phytochemistry 2003 62 817-836
15. Nicholson J K., Lindon J C., Holmes E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999 29 1181-1189
16. Nicholson J K., Lindon J C. Systems biology metabonomics. Nature 2008 455 1054-1056
17. Verpoorte R, Choi Y H., Mustafa N R., Kim H K. Metabolomics: back to basics. Phytochem Rev 2008 7 525-537
18. Beckonert O, Keun H C., Ebbels T M. D., Bundy J, Holmes E, Lindon J C., Nicholson J K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2007 2 2692-2703
19. Broberg A, Kenne L. Use of high-resolution magic angle spinning nuclear magnetic resonance spectroscopy for in situ studies of low-molecular-mass compounds in red algae. Anal Biochem 2000 284 367-374
20. Suggitt M, Bibby M C. 50 years of preclinical anticancer drug screening: Empirical to target-driven approaches. Clin Cancer Res 2005 11 971-981
21. Gibbs J B. Mechanism-based target identification and drug discovery in cancer research. Science 2000 287 1969-1972
22. Damia G, D'Incalci M. Contemporary pre-clinical development of anticancer agents what are the optimal preclinical models? Eur J Cancer 2009 45 2768-2781
23. Holbeck S L. Update on NCI in vitro drug screen utilities. Eur J Cancer 2004 40 785-793
24. Kinghorn A D., Farnsworth N R., Soejarto D D., Cordell G A., Swanson S M., Pezzuto J M., Wani M C., Wall M E., Oberlies N H., Kroll D J., Kramer R A., Rose W C., Vite G D., Fairchild C R., Peterson R W., Wild R. Novel strategies for the discovery of plant-derived anticancer agents. Pharm Biol 2003 41 53-67
25. Lin R Z., Chang H Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 2008 3 1172-1184
26. Kinghorn A D., Farnsworth N R., Beecher C W. W., Soejarto D D., Cordell G A., Pezzuto J M., Wall M E., Wani M C., Brown D M., O'Neill M J., Lewis J A., Besterman J M. Novel strategies for plant-derived anticancer agents. Int J Pharmacognosy 1995 33 48-58
27. Kinghorn A D., Farnsworth N R., Soejarto D D., Cordell G A., Pezzuto J M., Udeani G O., Wani M C., Wall M E., Navarro H A., Kramer R A., Menendez A T., Fairchild C R., Lane K E., Forenza S, Vyas D M., Lam K S., Shu Y-S. Novel strategies for the discovery of plant-derived anticancer agents. Pure Appl Chem 1999 71 1611-1618
28. Kinghorn A D., Farnsworth N R., Soejarto D D., Cordell G A., Swanson S M., Pezzuto J M., Wani M C., Wall M E., Oberlies N H., Kroll D J., Kramer R A., Rose W C., Vite G D., Fairchild C R., Peterson R W., Wild R. Novel strategies for the discovery of plant-derived anticancer agents. Pharm Biol 2003 41 53-67
29. Kinghorn A D., Su B N., Jang D S., Chang L C., Lee D, Gu J Q., Carcache-Blanco E J., Pawlus A D., Lee S K., Park E J., Cuendet M, Gills J J., Bhat K, Park H S., Mata-Greenwood E, Song L L., Jang M, Pezzuto J M. Natural inhibitors of carcinogenesis. Planta Med 2004 70 691-705
30. Balunas M J., Kinghorn A D. Drug discovery from medicinal plants. Life Sci 2005 78 431-441
31. Boros L G., Brackett D J., Harrigan G G. Metabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP). Curr Cancer Drug Targets 2003 3 445-453
32. 1H-NMR-based metabonomics. Nat Med 2002 8 1439-1444
33. Lindskog M, Spenger C, Jarvet J, Grslund A, Kogner P. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma. J Natl Cancer Inst 2004 96 1457-1466
34. Robertson D G. Metabonomics in toxicology: a review. Toxicol Sci 2005 85 809-822
35. Leo A D., Claudino W, Colangiuli D, Bessi S, Pestrin M, Biganzoli L. New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer. Ann Oncol 2007 18 8-14
36. Lindon J C., Holmes E, Nicholson J K. Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn 2004 4 189-199
37. Gribbestad I S., Sitter B, Lundgren S, Krane J, Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 1999 19 1737-1746
38. Sitter B, Lundgren S, Bathen T F., Halgunset J, Fjosne H E., Gribbestadl I S. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006 19 30-40
39. Spratlin J L., Serkova N J., Eckhardt S G. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009 15 431-440
40. Yang C, Richardson A D., Smith J W., Osterman A. Comparative metabolomics of breast cancer. Pac Symp Biocomput 2007 181-192
41. 1H HR-MAS spectroscopy. Magn Reson Med 2006 55 1257-1264
42. Yang J, Xu G, Zheng Y, Kong H, Pang T, Lva S, Yang Q. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B 2004 813 59-65
43. Griffin J L., Shockcor J P. Metabolic profiles of cancer cells. Nat Rev Cancer 2004 4 551-561
44. 1H-NMR-based metabonomics. Int J Cancer 2005 113 782-788
45. Robertson D G., Reily M D., Sigler R E., Wells D F., Paterson D A., Braden T K. Metabonomics: Evaluation of nuclear magnetic resonance and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 2000 57 326-337
46. Claudino W M., Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 2007 25 2840-2846
47. 31P NMR spectroscopy of cell extracts. Magn Reson Med 2007 58 270-280
48. Negendank W G. Studies of human tumors by MRS: a review. NMR Biomed 1992 5 303-324
49. 31P-magetic resonance spectroscopy study. Cancer Res 2001 61 7536-7543
50. Chung Y L., Griffiths J R. Using metabolomics to monitor anticancer drugs. Kroemer G, Mumberg D, Keun K, Riefke B, Steger-Hartmann T, Petersen K Oncogenes meet metabolism. Ernst Schering Foundation Symposium Procedings. Heidelberg Springer-Verlag 2008 55-78
51. Dixon R A., Sumner L W. Legume natural producs: understanding and manipulating complex pathways for human and animal health. Plant Physiol 2003 131 878-885
52. Zhi Biao-Yi, Yan Yu Y, Yi Zeng-Liang. Investigation of antimicrobial model of Hemsleya pengxianensis W.J. Chang and its main active component by metabolomics technique. J Ethnopharmacol 2008 116 89-95
53. Liu Y, Wen J, Wang Y, Li Y, Xu W. Postulating modes of action of compounds with antimicrobial activities through metabolomics analysis. Chromatographia 2010 71 253-258
54. Cardoso-Taketa A T., Pereda-Miranda R, Choi Y H., Verpoorte R, Villarreal M L. Metabolic profiling of the Mexican anxiolytic and sedative plant Galphimia glauca using nuclear magnetic resonance spectroscopy and multivariate data analysis. Planta Med 2008 74 1295-1301
55. Wold S, Sjstrm M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometrics Intell Lab Syst 2001 58 109-130
56. Holmes E, Antti H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterizing and interpreting complex biological NMR spectra. Analyst 2002 127 1549-1557
57. Trygg J, Wold S. O2-PLS, a two-block (XY) latent variable regression (LVR) method with an integrated OSC filter. J Chemom 2003 17 53-64
58. Rantalainen M, Cloarec O, Beckonert O, Wilson I D., Jackson D, Tonge R, Rowlinson R, Rayner S, Nickson J, Wilkinson R W., Mills J D., Trygg J, Nicholson J K., Holmes E. Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J Proteom Res 2006 5 2642-2655
59. Ebbels T M. D., Rachel Cavill R. Bioinformatic methods in NMR-based metabolic profiling. Prog Nucl Magn Reson Spectr 2009 55 361-374
60. Dunn W B. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Phys Biol 2008 5 1-24
61. Kell D B., Brown M, Hazel M, Davey H M., Dunn W B., Spasic I, Oliver S G. Metabolic footprinting and systems biology: the medium is the message. Nat Rev Microbiol 2005 3 557-565
62. Allen J, Davey H M., Broadhurst D, Rowland J J., Oliver S G., Kell D B. Discrimination of modes of action of antifungal substances by use of metabolic footprinting. Appl Environ Microbiol 2004 70 6157-6165
63. Verhoeckx K C. M., Bijlsma S, Jespersen S, Ramaker R, Verheij E R., Witkamp R F., van der Greef J, Rodenburg R J. T. Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination with multivariate data analysis. Int Immunopharmacol 2004 4 1499-1514
64. Xi Y, De Ropp J S., Viant M R., Woodruff D L., Yu P. Improved identification of metabolites in complex mixtures using HSQC NMR spectroscopy. Anal Chim Acta 2008 614 127-133
65. Kim H K., Saifullah, Khan S, Wilson E G., Prat Kricun S D., Meissner A, Goraler S, Deelder A M., Choi Y H., Verpoorte R. Metabolic classification of South American Ilex species by NMR-based metabolomics. Phytochemistry 2010 71 773-784
66. 13C NMR spectra. Anal Chem 2007 79 9385-9390